BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Standard BioTools Reports Third Quarter 2024 Financial Results

  October 31, 2024

   · 

  22 min read
• Press Releases

  Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test

  October 31, 2024

   · 

  4 min read
• Press Releases

  Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024

  October 31, 2024

   · 

  12 min read
• Press Releases

  Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combined with Ligufalimab (CD47) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), Compared to Pembrolizumab

  October 31, 2024

   · 

  5 min read
• Press Releases

  Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders

  October 31, 2024

   · 

  3 min read
• Press Releases

  Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook

  October 31, 2024

   · 

  11 min read
• Press Releases

  NANOBIOTIX to Participate in Multiple Investor Conferences in November 2024

  October 31, 2024

   · 

  2 min read
• Press Releases

  Cancer trial: retraining immune cells offers new hope for patients in personalized medicine breakthrough

  October 31, 2024

   · 

  4 min read
• Press Releases

  Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

  October 31, 2024

   · 

  5 min read
• Press Releases

  Bristol Myers Squibb Reports Third Quarter Financial Results for 2024

  October 31, 2024

   · 

  19 min read